Is ELEV or PLD a better dividend investment in 2026?

ELEV currently yields 547.95% with a 5% 5-year dividend growth rate. PLD yields 3.10% with 5% growth. The better choice depends on your goal: ELEV offers higher current income.

What is the dividend yield difference between ELEV and PLD?

ELEV has a forward dividend yield of 547.95% ($2.00/share annually). PLD yields 3.10% ($4.10/share annually). The yield gap is 544.85 percentage points.

Home › Compare › ELEV vs PLD

ELEV vs PLD: Dividend Comparison 2026

ELEV yields 547.95% · PLD yields 3.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ELEV wins by $125539.64M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ELEV

● Live price

547.95%

Share price

$0.37

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$125545.55M

Annual income

$92,380,482,230.31

Full ELEV calculator →

PLD

● Live price

3.10%

Share price

$132.18

Annual div

$4.10

5Y div CAGR

74.4%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5.91M

Annual income

$4,750,725.19

Full PLD calculator →

Portfolio growth — ELEV vs PLD

📍 ELEV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ELEV	PLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ELEV + PLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ELEV pays

PLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELEV

Annual income on $10K today (after 15% tax)

$46,575.34/yr

After 10yr DRIP, annual income (after tax)

$78,523,409,895.76/yr

PLD

Annual income on $10K today (after 15% tax)

$263.66/yr

After 10yr DRIP, annual income (after tax)

$4,038,116.41/yr

At 15% tax rate, ELEV beats the other by $78,519,371,779.35/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELEV + PLD for your $10,000?

ELEV: 50%PLD: 50%

100% PLD50/50100% ELEV

Portfolio after 10yr

$62775.73M

Annual income

$46,192,616,477.74/yr

Blended yield

73.58%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

ELEV

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$9.00

+2365.8% upside vs current

Range: $8.00 — $10.00

Altman Z

-4.8

Piotroski

1/9

PLD

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$136.00

+2.9% upside vs current

Range: $119.00 — $155.00

Altman Z

1.9

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELEV buys

PLD buys

No recent congressional trades found for ELEV or PLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricELEVPLD

Forward yield	547.95% ✓	3.10%
Annual dividend / share	$2.00	$4.10 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	74.4% ✓
Portfolio after 10y	$125545.55M ✓	$5.91M
Annual income after 10y	$92,380,482,230.31 ✓	$4,750,725.19
Total dividends collected	$122722.76M ✓	$5.78M
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Hold	Buy
Analyst price target	$9.00	$136.00 ✓

Year-by-year: ELEV vs PLD ($10,000, DRIP)

Year	ELEV Portfolio	ELEV Income/yr	PLD Portfolio	PLD Income/yr	Gap
1← crossover	$65,495	$54,794.52	$11,241	$540.96	+$54.3K → ELEV
2	$405,475	$335,396.34	$13,019	$991.13	+$392.5K → ELEV
3	$2,374,450	$1,940,591.70	$15,801	$1,870.97	+$2.36M → ELEV
4	$13,161,259	$10,620,596.57	$20,609	$3,701.21	+$13.14M → ELEV
5	$69,099,868	$55,017,321.36	$29,919	$7,867.97	+$69.07M → ELEV
6	$343,894,398	$269,957,539.26	$50,631	$18,617.74	+$343.84M → ELEV
7	$1,623,590,885	$1,255,623,879.22	$105,528	$51,352.20	+$1623.49M → ELEV
8	$7,277,465,834	$5,540,223,587.11	$287,364	$174,449.42	+$7277.18M → ELEV
9	$30,995,389,120	$23,208,500,677.65	$1,081,760	$774,280.77	+$30994.31M → ELEV
10	$125,545,548,589	$92,380,482,230.31	$5,908,209	$4,750,725.19	+$125539.64M → ELEV

ELEV vs PLD: Complete Analysis 2026

ELEV — Stock

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.

Full ELEV Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →

📬

Get this ELEV vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELEV vs SCHD ELEV vs JEPI ELEV vs O ELEV vs KO ELEV vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.